A Product and Pipeline Analysis of the Global Knee Cartilage Repair Market
A Product and Pipeline Analysis of the Global Knee Cartilage Repair Market
A New Standard of Care May be on the Horizon
19-Sep-2014
North America
$5,000.00
Special Price $3,750.00 save 25 %
Description
The standard of care, microfracture, does not fulfill long-term needs for patients with chondral defects. In addition, current alternative treatment options are plagued by multiple challenges and limitations. This research service focuses on medicine in the knee cartilage repair market, providing a detailed overview of 9 key products. A product and pipeline assessment is provided for marketed and investigational autologous cell-based therapy, allogenic cell-based therapy, and non-cellular products in the global, US, and European markets. Product profiles are included for companies that are currently or imminently marketing cell-based regenerative therapies and conducting clinical trials in the United States and Europe.
Table of Contents
Key Findings
Key Findings (continued)
The Ideal Knee Chondral Defect Repair Solution
Key Companies to Watch
Other Companies to Watch
Market Definitions
Market Opportunity
Market Overview
Market Overview (continued)
Market Overview (continued)
Market Overview (continued)
Market Overview (continued)
Market Overview (continued)
Market Overview (continued)
Market Overview (continued)
Current Cartilage Treatment Options
Significant Unmet Need Continues to Exist for Patients with Grades 3 and 4 Knee Chondral Defects
Technology Improvement Increases Product Utility
Market Drivers and Restraints
Recent Market Developments
Recent Market Developments (continued)
Knee Cartilage Repair Market—Competitive Landscape of Key Products
Knee Cartilage Repair Market—Competitive Landscape of Key Products (continued)
Differentiators for Key Marketed and Pipeline Products
Differentiators for Key Marketed and Pipeline Products (continued)
Differentiators for Key Marketed and Pipeline Products (continued)
Competitive Landscape—Pivotal Phase 3 Trials for Key Products
Competitive Landscape—Post-marketed Trials for Key Products
Global Estimated Approval Timelines for Key Products
Regulatory Pathway for Key Products
Knee Cartilage Repair Market—US Competitive Landscape of all Marketed and Pipeline Products
Marketed Product Analysis of Key Products—US
Pipeline Analysis of Key Products—US
US Competitive Landscape—Pivotal Phase 3 Trials
US Pivotal Phase 3 Trial Details
US Competitive Landscape—Post-marketed Trials
Knee Cartilage Repair Market—Europe Competitive Landscape of all Marketed Products
Knee Cartilage Repair Market—Europe Competitive Landscape of all Pipeline Products
Key Marketed Product Analysis—Europe
Key Marketed Product Analysis—Europe (continued)
Key Product Pipeline Analysis—Europe
Europe Competitive Landscape—Pivotal Phase 3 Trials
Europe Pivotal Phase 3 Trials
Europe Pivotal Phase 3 Trials (continued)
Europe Estimated Approval Timelines
NeoCart—Timelines for Focal Cartilage Defects
NeoCart—Clinical Trial Design Approach and Key Published Data
Product Dashboard—NeoCart
NovoCart 3D—US Timelines for Focal Cartilage Defects
NovoCart 3D—Europe Timelines for Focal Cartilage Defects
NovoCart 3D—Clinical Trial Design Approach and Key Published Data
NovoCart 3D—Clinical Trial Design Approach and Key Published Data (continued)
Product Dashboard—NovoCart 3D
RevaFlex—Timelines for Focal Cartilage Defects
RevaFlex—Clinical Trial Design Approach and Key Published Data
Product Dashboard—RevaFlex
Carticel—Clinical Trial Design Approach and Key Published Data
Carticel—Clinical Trial Design Approach and Key Published Data (continued)
Product Dashboard—Carticel
MACI—Clinical Trial Design Approach and Key Published Data
MACI—Clinical Trial Design Approach and Key Published Data (continued)
Product Dashboard—MACI
ChondroCelect—Clinical Trial Design Approach and Key Published Data
ChondroCelect—Clinical Trial Design Approach and Key Published Data (continued)
Product Dashboard—ChondroCelect
DeNovo NT—Clinical Trial Design Approach and Key Published Data
DeNovo NT—Clinical Trial Design Approach and Key Published Data (continued)
DeNovo NT—Clinical Trial Design Approach and Key Published Data (continued)
Product Dashboard—DeNovo NT
Product Dashboard—Cartiform
Product Dashboard—BioCartilage
Product Dashboard—Cartistem
Key Opinion Leader (KOL) Insights
Key Opinion Leader (KOL) Insights (continued)
Conclusions
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Related Research
No Index | No |
---|---|
Podcast | No |
Author | Jennifer Lazar |
WIP Number | NE07-01-00-00-00 |
Is Prebook | No |